Zhuhai Hospital, Jinan University, Zhuhai, Guangdong, China.
BMC Biochem. 2012 Nov 19;13:25. doi: 10.1186/1471-2091-13-25.
Nasopharyngeal carcinoma (NPC) has a high metastatic feature. N,N'-Dinitrosopiperazine (DNP) is involved in NPC metastasis, but its mechanism is not clear. The aim of this study is to reveal the pathogenesis of DNP-involved metastasis. 6-10B cells with low metastasis are from NPC cell line SUNE-1, were used to investigate the mechanism of DNP-mediated NPC metastasis.
6-10B cells were grown in DMEM containing 2H4-L-lysine and 13C 6 15 N4-L-arginine or conventional L-lysine and L-arginine, and identified the incorporation of amino acid by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Labeled 6-10B cells were treated with DNP at 0 -18 μM to establish the non-cytotoxic concentration (NCC) range. NCC was 0 -10 μM. Following treatment with DNP at this range, the motility and invasion of cells were detected in vitro, and DNP-mediated metastasis was confirmed in the nude mice. DNP increased 6-10B cell metastasis in vitro and vivo. DNP-induced protein expression was investigated using a quantitative proteomic. The SILAC-based approach quantified 2698 proteins, 371 of which showed significant change after DNP treatment (172 up-regulated and 199 down-regulated proteins). DNP induced the change in abundance of mitochondrial proteins, mediated the status of oxidative stress and the imbalance of redox state, increased cytoskeletal protein, cathepsin, anterior gradient-2, and clusterin expression. DNP also increased the expression of secretory AKR1B10, cathepsin B and clusterin 6-10B cells. Gene Ontology and Ingenuity Pathway analysis showed that DNP may regulate protein synthesis, cellular movement, lipid metabolism, molecular transport, cellular growth and proliferation signaling pathways.
DNP may regulate cytoskeletal protein, cathepsin, anterior gradient-2, and clusterin expression, increase NPC cells motility and invasion, is involved NPC metastasis.
鼻咽癌(NPC)具有较高的转移性特征。N,N'-二亚硝基哌嗪(DNP)参与 NPC 转移,但机制尚不清楚。本研究旨在揭示 DNP 参与转移的发病机制。低转移的 6-10B 细胞源自 NPC 细胞系 SUNE-1,用于研究 DNP 介导的 NPC 转移机制。
6-10B 细胞在含有 2H4-L-赖氨酸和 13C615N4-L-精氨酸或常规 L-赖氨酸和 L-精氨酸的 DMEM 中培养,并通过基质辅助激光解吸/电离飞行时间质谱法鉴定氨基酸掺入情况。用 DNP(0-18 μM)处理标记的 6-10B 细胞,建立非细胞毒性浓度(NCC)范围。NCC 为 0-10 μM。在此范围内用 DNP 处理后,检测细胞的迁移和侵袭能力,并在裸鼠中证实 DNP 介导的转移。DNP 增加了 6-10B 细胞在体外和体内的转移。使用定量蛋白质组学研究 DNP 诱导的蛋白表达。基于 SILAC 的方法定量了 2698 种蛋白质,其中 371 种在 DNP 处理后显示出显著变化(172 种上调和 199 种下调蛋白)。DNP 诱导线粒体蛋白丰度变化,介导氧化应激状态和氧化还原状态失衡,增加细胞骨架蛋白、组织蛋白酶、前梯度-2 和聚集素表达。DNP 还增加了分泌型 AKR1B10、组织蛋白酶 B 和聚集素 6-10B 细胞的表达。基因本体论和基因通路分析表明,DNP 可能调节蛋白质合成、细胞运动、脂质代谢、分子转运、细胞生长和增殖信号通路。
DNP 可能通过调节细胞骨架蛋白、组织蛋白酶、前梯度-2 和聚集素的表达,增加 NPC 细胞的迁移和侵袭,参与 NPC 转移。